MARKET

IDXG

IDXG

Interpace Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.04
-0.13
-2.11%
After Hours: 6.00 -0.04 -0.66% 16:57 08/13 EDT
OPEN
6.24
PREV CLOSE
6.17
HIGH
6.34
LOW
5.90
VOLUME
129.05K
TURNOVER
--
52 WEEK HIGH
11.00
52 WEEK LOW
3.810
MARKET CAP
24.38M
P/E (TTM)
-0.6932
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average IDXG stock price target is 13.45 with a high estimate of 20.00 and a low estimate of 9.25.

EPS

IDXG News

More
Interpace Announces Podium Presentation Accepted For American Society Of Cytopathology Annual Meeting
 Podium Presentation Accepted for the American Society of Cytopathology (ASC) Annual Meeting PARSIPPANY, NJ, July 21, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ:IDXG) announced today that a
Benzinga · 07/21 10:07
Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid Assays
Podium Presentation Accepted for the American Society of Cytopathology (ASC) Annual Meeting PARSIPPANY, NJ, July 21, 2020 -- Interpace Biosciences, Inc. (NASDAQ: IDXG).
GlobeNewswire · 07/21 10:05
Edited Transcript of IDXG earnings conference call or presentation 25-Jun-20 8:30pm GMT
Q1 2020 Interpace Biosciences Inc Earnings Call
Thomson Reuters StreetEvents · 07/13 22:39
65 Biggest Movers From Yesterday
Gainers MOGU Inc. (NASDAQ: MOGU) shares climbed 104.8% to close at $5.92 on Tuesday.
Benzinga · 07/08 10:05
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 07/06 09:18
NUS, CPST, SOLO and MEIP among midday movers
Seeking Alpha - Article · 07/02 16:42
TSLA, PLUG among premarket gainers
Seeking Alpha - Article · 07/02 12:17
Interpace Q1 revenue +53%, shares -7.5%
Seeking Alpha - Article · 06/26 14:52

Industry

Managed Health care
-0.43%
Healthcare Providers & Services
-1.50%

Hot Stocks

Symbol
Price
%Change

About IDXG

Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
More

Webull offers kinds of Interpace Biosciences Inc stock information, including NASDAQ:IDXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXG stock methods without spending real money on the virtual paper trading platform.